CLINICAL CASE OF THROMBOLYTIC THERAPY OF RECURRENT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENT WITH LONG HISTORY OF ISCHEMIC HEART DISEASE

Abstract

Presented case report demonstrates the efficacy and safety of hospital use of thrombolytic agent Fortelizin in pharmaco-invasive strategy for the treatment of a patient with acute myocardial infarction and with a long history of ischemic heart disease and long-term dynamics of the verified angiographic progression of coronary atherosclerosis. Hospital thrombolytic therapy with Fortelizin was vital alternative in case of a substantial time delay in mechanical reperfusion of the myocardium.

Keywords

• fortelizin
• acute myocardial infarction
• pharmacoinvasive strategy